New BTK Inhibitor Makes Case for Earlier Use in CLL

(MedPage Today) -- ORLANDO--Patients with newly diagnosed chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) lived significantly longer without disease progression when treated with the Bruton's tyrosine kinase (BTK) inhibitor...